Logo
x

Search

Subscribe Now

CStone Pharmaceuticals

CStone Pharmaceuticals’s Cejemly (Sugemalimab) Receives the EC’s Approval to Treat Non-Small Cell Lung Cancer

CStone Pharmaceuticals’s Cejemly (Sugemalimab) Receives the EC’s Approval to Treat Non-Small Cell Lung Cancer

  • July 29, 2024
CStone Pharmaceuticals’ Cejemly Receives the CHMP’s Positive Opinion for Treating NSCLC

CStone Pharmaceuticals’ Cejemly Receives the CHMP’s Positive Opinion for Treating NSCLC

  • June 3, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.